Trial NCT00004221

View at ClinicalTrials.gov 
Org. Study IDs: GOG-9903
Secondary IDs: CDR0000067462 GOG-9903 NCI-2012-02312 U10CA027469

Last trial update was posted on 2017-08-09

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Cyclophosphamide Lenograstim Paclitaxel Topotecan

MeSH Conditions

Carcinoma Carcinoma, Endometrioid Carcinoma, Ovarian Epithelial Cystadenocarcinoma Cystadenocarcinoma, Mucinous Cystadenocarcinoma, Serous Ovarian Neoplasms

Other Conditions

Malignant Ovarian Mixed Epithelial Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Primary Peritoneal Carcinoma Stage III Ovarian Cancer Undifferentiated Ovarian Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID